Correlation between serum content of cytokines and neuropeptides in children with recurrent bronchitis and vertebrobasilar arterial system syndrome


  • L.S. Ovcharenko State Institution “Zaporizhzhia Medical Academy of Postgraduate Education of the Ministry of Health of Ukraine”, Zaporizhzhia, Ukraine
  • T.V. Slutska State Institution “Zaporizhzhia Medical Academy of Postgraduate Education of the Ministry of Health of Ukraine”, Zaporizhzhia, Ukraine



children, bronchitis, immunity, neuropeptides


Background. The presence of nervous regulation imbalance in children is a cause of bronchopulmonary pathology with severe clinical course. The study of neuroimmune relationships in children with vertebrobasilar arterial system syndrome and acute bronchitis will allow establishing important elements in the pathogenesis of this combination. Objective: to determine neuroimmune relationships in children with vertebrobasilar arterial system syndrome causing the formation of recurrent acute bronchitis. Materials and methods. We have examined 60 children aged 7 to 12 years. Two groups were formed (30 children each): 1) patients with vertebrobasilar arterial system syndrome and acute bronchitis; 2) children without vertebrobasilar arterial system syndrome and acute bronchitis. Results. The children of group 1 in comparison with the children of group 2 more frequently had a decrease in the phagocytic number (by 56.7 %; p < 0.05), phagocytic index (by 53.3 %; p < 0.05), phagocytosis completeness index (by 66.7 %; p < 0.05), stimulated nitroblue tetrazolium test (by 40.0 %; p < 0.05). When studying adaptive immunity, an increase was detected in the number of group 1 children with elevated serum CD3+ (by 40.0 %; p < 0.05), CD4+ (by 33.4 %; p < 0.05), CD8+ (46.7 %; p < 0.05), CD25+ (83.3 %; p < 0.05) levels, increased serum content of IgG (by 33.3 %; p < 0.05) and IgM (54.3 %; p < 0.05) against the background of a decrease in IgA (by 40.0 %; p < 0.05). Children of group 1 had elevated serum levels of tumor necrosis factor a (by 70.0 %; p < 0.05) and a decrease in interleukin-10 (by 40.0 %; p < 0.05), along with increased concentration of substance P (by 40.0 %; p < 0.05) and a decrease of vasoactive intestinal peptide (by 30.0 %; p < 0.05). Conclusions. In children with the vertebrobasilar arterial system syndrome and acute bronchitis, pro-inflammatory cytokines and neuropeptides predominate in the blood serum, with insufficiency of anti-inflammatory substances.


Mashaghi A, Marmalidou A, Tehrani M, Grace PM, Pothoulakis C, Dana R. Neuropeptide substance P and the immune response. Cell Mol Life Sci. 2016 Nov;73(22):4249-4264. doi: 10.1007/s00018-016-2293-z.

Sun J, Bhatia M. Substance P at the neuro-immune crosstalk in the modulation of inflammation, asthma and antimicrobial host defense. Inflamm Allergy Drug Targets. 2014;13(2):112-20.

Chedid P, Boussetta T, Dang PM, et al. Vasoactive intestinal peptide dampens formyl-peptide-induced ROS production and inflammation by targeting a MAPK-p47 phox phosphorylation pathway in monocytes. Mucosal Immunol. 2017 Mar;10(2):332-340. doi: 10.1038/mi.2016.51.

Gross NJ, Barnes PJ. New therapies for asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2017 Jan 15;195(2):159-166. doi: 10.1164/rccm.201610-2074PP.

Numis AL, Fox CK. Arterial ischemic stroke in children: risk factors and etiologies. Curr Neurol Neurosci Rep. 2014 Jan;14(1):422. doi: 10.1007/s11910-013-0422-8.

Papaioannou AI, Bostantzoglou C, Kontogianni C, Gaga M. Upper and lower airways: the same tissue? In: Bachert C, Bourdin A, Chanez P, editors. The Nose and Sinuses in Respiratory Disorders. Sheffield: European Respiratory Society; 2017. 1-11 pp. doi: 10.1183/2312508X.10009316.

Yang C, Gao J, Du J, Yang X, Jiang J. Altered Neuroendocrine Immune Responses, a Two-Sword Weapon against Traumatic Inflammation. Int J Biol Sci. 2017 Nov 1;13(11):1409-1419. doi: 10.7150/ijbs.21916.

Mescher AL, Neff AW, King MW. Inflammation and immunity in organ regeneration. Dev Comp Immunol. 2017 Jan;66:98-110. doi: 10.1016/j.dci.2016.02.015.

Hazeldine J, Lord JM, Belli A. Traumatic Brain Injury and Peripheral Immune Suppression: Primer and Prospectus. Front Neurol. 2015 Nov 5;6:235. doi: 10.3389/fneur.2015.00235.

Chang AB, Upham JW, Masters IB, et al. Protracted bacterial bronchitis: the last decade and the road ahead. Pediatr Pulmonol. 2016 Mar;51(3):225-42. doi: 10.1002/ppul.23351.

Bodkin JV, Fernandes ES. TRPV1 and SP: Key elements for sepsis outcome? Br J Pharmacol. 2013 Dec;170(7):1279-92. doi: 10.1111/bph.12056.

Lorente L, Martín MM, Pérez-Cejas A, et al. Sustained Low Serum Substance P Levels in Non-Surviving Septic Patients. Int J Mol Sci. 2017 Jul 15;18(7). pii: E1531. doi: 10.3390/ijms18071531.

Jiang MH, Lim JE, Chi GF, et al. Substance P reduces apoptotic cell death possibly by modulating the immune response at the early stage after spinal cord injury. Neuroreport. 2013 Oct 23;24(15):846-51. doi: 10.1097/WNR.0b013e3283650e3d.



Clinical Pediatrics